APOA5 and stroke disorder: The rs2266788 polymorphism disrupts microRNA-3201 binding in the 3′ UTR of APOA5, increasing mRNA stability and expression, a potential pathway for dysregulated lipid metabolism in stroke or SCZ [101,102,103].